Stocks · News reference
Acuren (NYSE:TIC) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. The company reported quarterly sales of $584.347 million which beat the analyst
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wall Street analysts upgraded Parsons Corp, InnovAge Holding Corp, Equifax Inc, and initiated coverage on Builders FirstSource, Inc and Nuvation Bio Inc.
Read original at benzingaJP Morgan analyst Tomohiko Sano upgrades TIC Solutions (NYSE:TIC) from Underweight to Neutral and raises the price target from $9 to $11.
Read original at benzinga- Expands TIC Solutions’ capabilities and geographic reach across key end markets -- Acquired businesses contribute a total of approximately $90 million of annualized revenue -- Accretive to TIC Solutions’
Read original at benzingaUBS analyst Joshua Chan upgrades TIC Solutions (NYSE:TIC) from Neutral to Buy and raises the price target from $11 to $12.5.
Read original at benzinga